GLENMEDE TRUST CO NA - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 97 filers reported holding CYTOSORBENTS CORP in Q3 2020. The put-call ratio across all filers is 1.36 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2020$17,000
-15.0%
2,229
+3.1%
0.00%
Q2 2020$20,000
+150.0%
2,1610.0%0.00%
Q1 2020$8,0000.0%2,1610.0%0.00%
Q4 2019$8,000
-20.0%
2,1610.0%0.00%
Q3 2019$10,000
-28.6%
2,1610.0%0.00%
Q2 2019$14,000
-12.5%
2,1610.0%0.00%
Q1 2019$16,0000.0%2,1610.0%0.00%
Q4 2018$16,000
-83.7%
2,161
-75.1%
0.00%
Q2 2018$98,000
-16.2%
8,662
-54.4%
0.00%
-100.0%
Q3 2017$117,000
+39.3%
19,0080.0%0.00%
Q2 2017$84,0000.0%19,0080.0%0.00%
Q1 2017$84,000
-17.6%
19,0080.0%0.00%
-100.0%
Q4 2016$102,000
-15.7%
19,0080.0%0.00%0.0%
Q3 2016$121,000
+42.4%
19,0080.0%0.00%0.0%
Q2 2016$85,000
+16.4%
19,0080.0%0.00%
Q1 2016$73,000
-30.5%
19,0080.0%0.00%
-100.0%
Q4 2015$105,000
-39.3%
19,008
-31.2%
0.00%0.0%
Q3 2015$173,000
+2.4%
27,6480.0%0.00%0.0%
Q2 2015$169,000
-53.6%
27,6480.0%0.00%
-66.7%
Q1 2015$364,000
+32.8%
27,6480.0%0.00%
+50.0%
Q4 2014$274,00027,6480.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q3 2020
NameSharesValueWeighting ↓
CM Management, LLC 450,000$846,0000.90%
Skylands Capital, LLC 2,944,670$5,535,9800.84%
Sargent Investment Group, LLC 1,257,048$2,363,2500.57%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 197,940$372,1270.52%
Avenir Corp 2,717,397$5,108,7060.48%
Granahan Investment Management 1,552,393$2,918,4990.10%
Seelaus Asset Management LLC 20,450$38,4460.04%
HighMark Wealth Management LLC 10,000$18,8000.02%
Key Client Fiduciary Advisors, LLC 13,000$24,4400.02%
Eudaimonia Partners, LLC 23,500$44,1800.01%
View complete list of CYTOSORBENTS CORP shareholders